Professor, Pediatrics - Infectious Diseases, Stanford University School of Medicine and Medical Director, Stanford-LPCH Vaccine Program
Pediatric Infectious Disease
Dr. Cornelia L. Dekker, MD
|
|
Give Review
Cornelia Dekker works in the field of Pediatric Infectious Disease. Cornelia Dekker is a published doctor and has 64 publications published. The lastest was: 'Annotated bibliography: general research texts and statistics.'
Publications
- Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine.
- Variation in the human immune system is largely driven by non-heritable influences.
- Distinct patterns of B-cell activation and priming by natural influenza infection versus inactivated influenza vaccination.
- The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.
- Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.
- Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines.
- Effects of Aging, Cytomegalovirus Infection, and EBV Infection on Human B Cell Repertoires.
- Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination.
- Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS.
- Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry.
- Genetic measurement of memory B-cell recall using antibody repertoire sequencing.
- Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults.
- Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers.
- Lineage structure of the human antibody repertoire in response to influenza vaccination.
- Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.
- Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine.
- Biologically plausible and evidence-based risk intervals in immunization safety research.
- Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older perso...
- Algorithm to assess causality after individual adverse events following immunizations.
- Lack of association between childhood immunizations and encephalitis in California, 1998-2008.
- Developing the next generation of vaccinologists.
- Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination.
- Rotavirus shedding in premature infants following first immunization.
- Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
- Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.
- Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.
- Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route ...
- Recurrent sterile abscesses following aluminium adjuvant-containing vaccines.
- Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
- Attitudes and beliefs of parents concerned about vaccines: impact of timing of immunization information.
- Plasmablast-derived polyclonal antibody response after influenza vaccination.
- Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.
- Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control study.
- Preterm infants' T cell responses to inactivated poliovirus vaccine.
- Differential maternal responses to a newly developed vaccine information pamphlet.
- Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adu...
- One step closer to a CMV vaccine.
- An algorithm for treatment of patients with hypersensitivity reactions after vaccines.
- Influence of prior influenza vaccination on antibody and B-cell responses.
- Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.
- Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.
- Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.
- Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines.
- Risk factors for developing apnea after immunization in the neonatal intensive care unit.
- A role for genetics in the immune response to the varicella vaccine.
- Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
- Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza vi...
- Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.
- Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults.
- T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.
- Selective developmental defects of cord blood antigen-presenting cell subsets.
- Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood.
- Pediatric uses of valacyclovir, penciclovir and famciclovir.
- Antiviral agents effective against herpesviruses.
- Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group.
- A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected].
- Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide...
- Annotated bibliography: general research texts and statistics.
- Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children.
- Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old chi...
- Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children.
- Apoptosis and other immune biomarkers predict influenza vaccine responsiveness.
- Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals.
Doctors Specialties
- Pediatrics
- Pediatric Infectious Disease
Accepted Insurances
Education
-
Duke University Hospital -
Michigan State University College of Human Medicine
Hospital
-
Stanford Health Care -
Lucile Packard Children's Hospital Stanford
Helpful Reviews
Similar Doctors
|
|
Dr. Megumi Itoh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan S. Huss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Nelson, MD |
|
|
Dr. Petra Mamic, MD |
|
|
Dr. Kara A. Dubray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon F. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hayley A. Gans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nivedita S. Srinivas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles Prober, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Devasena Gnanashanmugam, MB
This Doctor is OpenDoctor Recommended.
|